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Abstract
Background: Polyclonal B-cell activation is well known to occur in Plasmodium infections, but its
role in pathogenesis or protection remains unclear. However, protective properties of natural
antibodies have previously been demonstrated in other contexts.
Methods: Sera from asymptomatic and symptomatic Plasmodium-infected subjects locally detected
in a survey study in the Brazilian Amazon, and from unexposed and exposed but presently
uninfected control subjects, were assayed by a standardized quantitative immunoblot method
allowing simultaneous detection of IgG or IgM reactivity to a large number of parasite-unrelated
proteins.
Results: In subjects free of coinfection with hepatitis B virus, IgG reactivity to human brain antigens
and Escherichia coli proteins was strikingly enhanced in asymptomatic Plasmodium-infected
individuals when compared to such with clinical malaria symptoms, or to uninfected control
subjects. This difference was most characteristic for limited exposure times (less than ten years
locally, or 20 years in endemic areas). It was more significant than a similar trend found for IgG to
Plasmodium falciparum antigens, and unrelated to parasitaemia levels. Asymptomatic subjects with
comparatively short exposure characteristically showed relatively elevated IgG versus IgM
reactivity. Polyclonal IgG reactivity appears triggered by previous P. falciparum but not Plasmodium
vivax malaria.
Conclusion: The observed difference in polyclonal antibody production seems related to intrinsic
activation states of infected individuals, rather than to parasite-antigen specific immune responses.
However, it appears influenced by preceding stimuli. This supports the idea that acquired clinical
immunity may not exclusively depend on antigen-specific responses, but also on the individual
polyclonal reaction.
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Malaria remains an important health problem in sub-
Saharan Africa and in some parts of Asia and South Amer-
ica. Resistance to therapeutic drugs and to insecticides, as
well as social and environmental changes, are important
factors in this situation. Increasing importance is currently
given to antibodies in protection against human malaria,
especially directed at erythrocytic stages of Plasmodium fal-
ciparum [1]. However, this protection is relatively unsta-
ble, and the precise role of specificities remains unclear
regarding the antigenic variability of parasite proteins.
Although parasite-specific antibodies clearly contribute to
protection, it is not evident to which extent protective
antibodies in general originate from specific immune
responses to parasite antigens. They may also include
components of innate immunity and be in part derived
from natural antibody repertoires of the host. The remark-
able protective properties of natural antibodies have pre-
viously been demonstrated in viral and bacterial [2-4] as
well as in Leishmania [5] infection, and it appears conceiv-
able that analogous properties exist toward Plasmodium
parasites, either naturally or selected during the long co-
evolution of the human species with these parasites. An
example may be autoantibodies to 'band 3', a host-
encoded target on cell membranes, involved in protection
against malaria [6,7] as well as physiologic cellular life
span regulation [8].
Natural antibodies, immunoglobulins circulating in the
absence of particular immunogenic stimuli, emerge from
continuous autonomous activity of the immune system
which appears largely independent of any external prim-
ing, as demonstrated e. g. in germ-free and antigen-free
mice [9,10]. They are often multireactive, and a large pro-
portion interacts with endogenous targets and may play
roles in internal homeostasis [11]. Reactivity patterns of
IgM and IgG natural antibodies to autologous tissue pro-
teins appear established early in life and remain remarka-
bly stable throughout healthy living [12], but are capable
of characteristic changes in autoimmune [13,14] and
other [15,16] human diseases. Thus, such patterns are
likely to reflect stabilized states of physiologic activation,
shaped by polymorphic genes relevant for the immune
system [17] which can be selected in evolution.
The aim of this study was to investigate whether likely nat-
ural antibody reactivity patterns measured toward targets
not related to parasites, but rather derived from autolo-
gous tissue or intestinal flora, could differentiate between
asymptomatic and symptomatic forms of malarial infec-
tion. Asymptomatic infection is frequent in the Brazilian
Amazon [18], even without very long exposure times,
although malaria is only hypo- to mesoendemic and
transmission is unstable with seasonal fluctuations [19].
Nevertheless, the situation appears analogous to hyperen-
demic regions, where parasite loads are known to gradu-
ally diminish with exposure time, resulting in a state of
premunition, in which the still chronically infected sub-
jects nevertheless remain asymptomatic for long periods
[20,21]. Asymptomatic infection can also be maintained
after clinical cure by antimalarial drugs [22], showing that
protection from disease can be very distinct from parasite
clearance, which may paradoxically even enhance the risk
of clinical relapses [23].
Asymptomatic and symptomatic subjects who are studied
here were occasionally detected in a survey study of
endemic Brazilian populations. They mainly consisted of
migrants who lived in endemic areas for individually dif-
ferent time periods, and may have experienced sequential
infections by P. falciparum or Plasmodium vivax, with clin-
ical symptoms of variable degrees of intensity but low
reported mortality [24]. Results showed that asympto-
matic and symptomatic states could be remarkably well
distinguished by multi-specific antibody reactivity, partic-
ularly when exposure times were limited, and that the dis-
tinction consisted more in a difference in nonspecific
polyclonal activation than in a specific immunization
effect.
Materials and Methods
Study areas and subjects
78 sera analysed here originated from subjects exposed to
transmission in the Brazilian Amazon endemic area, who
had variable numbers of reported previous episodes of P.
vivax or P. falciparum clinical malaria. The malaria-
exposed subjects comprised three distinct groups [see
Additional file 1]. The principal study group was derived
from a screening of 531 miners living in gold-mining
areas in the municipality of Apiacás (AP), Mato Grosso,
among whom 99 had been found parasitaemic, present-
ing with positive Giemsa-stained thick-blood smears [25].
Out of these 99 subjects, only 46 had shown classical
malaria symptoms within 72 hours after parasite detec-
tion, while the other 53 had remained asymptomatic.
Symptoms were mainly headache, anorexia and fever.
Included in the present study are 48 of these miners, 24
symptomatic and 24 asymptomatic, who had lived for up
to 17 years in Apiacás. There was no significant difference
between symptomatic and asymptomatic individuals in
their time of residence. According to anamnestic reports,
numbers of previous malaria episodes were highly varia-
ble, but neither significantly different between the groups.
The time elapsed since the respective last episode, how-
ever, was significantly longer among the asymptomatics
(see Table 1). Within these parasitaemic subgroups, sub-
jects were further distinguished whether or not they were
positive for hepatitis B surface antigen (HbSAg) and there-
fore hepatitis B virus (HBV) carriers. Two further groups
included exposed, but aparasitaemic control subjects. ThePage 2 of 15
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in Terra Nova Norte (TNN), a small rural community
within the endemic region, continuously exposed to
malaria. These parasitologically negative, convalescent
individuals had been treated for malaria only until two
months before the blood collection (Aparasitaemic/Previ-
ous malaria). The second group (10 subjects) also lived in
TNN, but had no record of previous malarial episodes
(Aparasitaemic/No previous malaria). All subjects
responded to a questionnaire including information on
past malaria and previous treatments. Consent to draw
blood was obtained from each individual according to the
Fundação Oswaldo Cruz Ethics Committee (MH, Novem-
ber 26th, 1994) and to the Universidade Federal de Minas
Gerais Ethics Committee (April 15th, 1998). Venous
blood samples (20 ml per subject) were drawn in Vacu-
tainer™ (Becton Dickinson, Oxnard, CA) heparinized
tubes. Giemsa-stained thick-blood smears were examined
at this point for blood parasitaemia. Finally, a third con-
trol group consisted of 10 healthy adult volunteers from
Belo Horizonte (Minas Gerais) who had never been
exposed to malaria transmission or visited endemic
regions (Aparasitaemic/Not exposed). IgG and IgM to
human brain proteins were assessed in the subjects
described above. When measuring IgG reactivity to E. coli
proteins, two of the Terra Nova and seven of the Apiacas
subjects were not included, but replaced by one Terra
Nova and eight Apiacas subjects not assayed for reactivity
to brain proteins.
Parasitaemia and anti-P. falciparum reactivities
The parasite density was quantified after examination of
200 microscopic fields at 1.000× magnification under oil-
immersion. All slides were examined by three well-trained
microscopists. Blood parasitaemia was expressed as the
number of parasites per 200 leukocytes. Parasitaemia and
reactivity to P. falciparum and MSP1-19 in these popula-
tions have been analysed and described previously [25].
Immunoblot Assay
The assay was done as described [26]. Briefly, protein
extracts from human brain and cultured E. coli were run in
a discontinuous SDS-PAGE 10% gel (Mighty Small elec-
trophoresis apparatus, Hoefer Scientific Instruments, San
Francisco, CA). After eletrophoresis, proteins were trans-
ferred onto a nitrocellulose membrane (Schleicher &
Schuell, Germany) in a semi-dry system for one hour at
0.8 mA/cm2. After overnight blocking of free binding sites
in PBS-Tween 0.2%, membranes were incubated for four
hours with sera, diluted 1/20, in incubation units fixing
membranes in cassettes with 28 independent channels
(Miniblot System C-Shell, Immunetics Inc., Cambridge,
MA). Whole membranes were then washed and incubated
for 90 minutes at room temperature with secondary anti-
Table 1: Composition of the sample studied
Group Origin Nb Age1 Residence1 Previous malaria2 Time elapsed since 
last episode1
Aparasitaemic Not 
Exposed
B. Horizonte 10 27–55 [31] 0
Aparasitaemic – 
No Previous 
Malaria
Terra Nova 10 16–39 [27] 0
Aparasitaemic – 
Previous Malaria
Terra Nova 20 14–35 [27.5]4 1–11 [3]3
Parasitaemic – 
HBV-negative 
Asymptomatic
Apiacas 19 20–47 [30] 2–13 [8]4 2–70 [15] 0–13 [2 years]3
Parasitaemic – 
HBV-negative 
Symptomatic
Apiacas 13 6–66 [27] 2–17 [7]3 2–50 [15] 0–17 [1 month]
Parasitaemic – 
HBV-positive 
Asymptomatic
Apiacas 5 20–50 [27] 2–11 [6] 7–50 [15] 0–4 [1 year]
Parasitaemic – 
HBV-positive 
Symptomatic
Apiacas 11 24–46 [30] 5–11 [10]4 5–50 [35] 0–2 [2 months]
1 In years; range [median]
2 Number of malaria episodes anamnestically reported; range [median]
3 Unknown for one subject
4 Unknown for two subjectsPage 3 of 15
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(Southern Biotech, Birmingham, AL). Reactivies were
revealed with NBT/BCIP (nitroblue-tetrazolium/bromo-
chloro-indolyl-phosphate) substrate (Promega, Madison,
WI) for three to five minutes, and membranes scanned in
8-bit grayscale and with 600 dpi resolution in a domestic
scanner (Apple Color OneScanner). Thereafter, mem-
branes were stained overnight with colloidal gold (Biorad,
Hercules, CA) to reveal total protein and again scanned as
described.
Data processing and statistical analysis
The method of data processing has been described [26].
Briefly, reactivity profiles from the scanned immunoblot
image were adjusted for migration irregularities during
electrophoresis, using the scan of the same membrane
stained for total protein. Special procedures programmed
with the software IgorPro (Wavemetrics, Lake Oswego,
OR) on a Macintosh computer (Apple computers, Cuper-
tino, CA) were applied in order to represent each serum
sample as a profile on a standardized migration scale,
with the optical density (OD) as a function of migration
distance. After this rescaling, sections were defined by
intervals on the standardized migration scale around reac-
tivity peaks, and, after baseline subtraction, reactivity for
each section and serum was quantified as the average OD
within a respective section. In this way, each serum can be
represented by a vector with a dimension equal to the
number of sections, containing the respective reactivity
quantitation. In order to make these data commensurate
across membranes, they were further normalized by the
membrane-wise average reactivity of a unique standard
(pool of human IgM or IgG), assayed twice on each
membrane.
These vectors were then analysed by Principal Component
Analysis (PCA). PCA is a classic method of multivariate
analysis designed to describe multidimensional data with
high dimensionality through projection onto characteris-
tic subspaces with lower dimensionality. Principal com-
ponents are defined in a mathematically strict manner as
orthogonal axes fitting maximal information in terms of
total variance with decreasing proportion and uncorre-
lated among each other. This includes no information on
experimental groups or other particularities, but provides
a completely neutral and unbiased description of the data
set as such.
The number of bands detected on a respective extract was
quantified as the number of sections showing reactivity
values two-fold above the average reactivity of the stand-
ard used for adjustment. Total reactivity for a given extract
was assessed as the average OD over the entire migration
scale, from the first to the last section. Only distribution-
independent statistics were used: Mann-Whitney rank
sum test and Spearman rank correlation. P-values below
0.05 were considered significant.
Results
IgG reactivity to human brain proteins
As an example, Fig. 1 shows one representative out of four
total immunoblot membranes on which IgG reactivities
to brain proteins were assayed. Most of the reactivity
bands appear in samples derived from asymptomatic par-
asitaemic subjects, with the exception of one symptomatic
coinfected with HBV. In Fig. 2, three different (however,
correlated) ways to evaluate the reactivity quantitatively
are shown : (1) by the number of detected bands; (2) by
the summation of total reactivity in terms of averaged
optical density over the whole migration scale; (3) by the
score of the first principal component calculated from
standardized optical densities of all reactivity bands. By
any of these criteria, asymptomatic parasite carriers from
Apiacas showed more reactivity than parasite-free subjects
in all groups with high significance (p < 0.00001). Para-
site carriers with symptoms, however, also had less reac-
tivity and, provided that they were not coinfected with
HBV, did not significantly differ from parasite-free sub-
jects. Among symptomatics, only HBV-positives showed
reactivity levels comparable to the asymptomatics. In the
absence of HBV-coinfection, asymptomatic and sympto-
matic subjects differed with high significance in terms of
all three reactivity measures (p = 0.0003, 0.0002 and
0.0001, respectively). Even disregarding the presence of
HBV coinfection, this difference was still significant (p =
0.017, 0.008 and 0.005, respectively). Assays of specific
anti-parasite reactivity in the same subjects (reported in
[25]) are shown in Fig. 2 for comparison. Although show-
ing the same tendency, these specific assays were less dis-
criminatory, considering either only HBV-negative (IgG
anti-P. falciparum: p = 0.034; IgG anti-MSP1-19: nonsig-
nificant) or all parasitaemic individuals (p = 0.017 and p
= 0.014, respectively).
The first principal component (PCA factor 1) is, by defini-
tion, the linear combination of single reactivity measure-
ments which represents a maximum of information about
a multivariate dataset in terms of total variance, here 34%.
Since this is the most systematic quantitative representa-
tion, the analysis will be continued based on principal
components. In PCA, factor loads, i. e., coefficients indi-
cating the relative contribution of measured parameters to
the respective factor score, can be interpreted according to
whether this factor represents a general level difference or
a pattern-related property. Here, the factor-1 score con-
tained only positive loads and, thus, represents a modi-
fied measure of total reactivity. Factor-1 scores indeed
showed similar groupwise distributions as band number
or total reactivity and were most discriminating. AmongPage 4 of 15
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one with interpretable properties.
Further properties of factor-1 scores derived from IgG
anti-brain reactivities are shown in Fig. 3, 4, 5. Parasitae-
mic subjects had provided information on the time they
had spent in Apiacas and in malaria-endemic areas in gen-
eral. When plotted against these exposure times (Fig. 3),
factor-1 scores discriminated best between asymptomatic
and symptomatic subjects without HBV coinfection who
had been exposed for relatively shorter periods. Hence,
HBV-free subjects living less than 10 years in Apiacas or
less than 20 years in malaria-endemic areas were almost
completely separated according to their clinical status by
factor-1 scores, but not those with long-term exposure.
HBV-coinfected subjects, however, all displayed enhanced
scores with no evident relationship to malaria exposure.
For instance, both exposure parameters did not differ
IgG reactivity patterns to brain proteins on one of four membranesFigure 1
IgG reactivity patterns to brain proteins on one of four membranes. Open circles indicate asymptomatic malaria, closed circles 
symptomatic malaria in HBV-free parasite carriers, open and closed rhombi analogously in HBV-coinfected subjects. N indi-
cates unexposed (Belo Horizonte), X and + exposed aparasitemic subjects from Terra Nova without and with previous 
malaria, respectively. Unmarked intermediate lanes contain the standard used for adjustment.Page 5 of 15
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Comparison of properties of anti-brain IgG immunoblot reactivity andantiplasmodial IgG. A. Immunoblot of IgG to human brain 
proteins: number of bands, total reactivity and PCA factor-1 scores for IgG reactivities for each patient group. B. Antiplasmo-
dial IgG: equivalent displays of data from the same patients for IgG reactivity to anti-P. falciparum and anti-PfMSP1-19. In both 
panels, medians for each group are indicated by vertical bars. C. factor loads for PCA factor-1 shown in panel A.Page 6 of 15
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subjects, regardless whether HBV infection is taken into
account or not.
Fig. 4 shows the relationship between factor-1 scores and
(a) individual parasitaemia and (b) anti-parasite IgG.
Within HBV-negative asymptomatic subjects, scores were
highest when parasitaemia levels were relatively low,
although this association was quantitatively insignificant.
A significant correlation was found between factor-1
scores and IgG reactivity to P. falciparum (Spearman rank
correlation: +0.57 [p < 0.00001] including parasitaemics
and exposed aparasitaemics; +0.37 [p = 0.011] within par-
asitaemics only), or to PfMSP1-19 (Spearman R, consider-
ing parasitaemics and exposed aparasitaemics: +0.42 [p =
0.0002]; not shown). Nevertheless, as can be seen in Fig.
4 for IgG anti-P. falciparum, these correlations are mainly
due to the fact that all parameters were relatively
Polyclonal reactivity and exposureFigure 3
Polyclonal reactivity and exposure. Scores of PCA factor-1, derived from IgG reactivity to brain proteins, in relation to the 
time spent in Apiacas and in malaria-endemic zones, for HBV-negative (left) and HBV-positive subjects (right). Open symbols 
indicate asymptomatic, closed symbols symptomatic subjects.Page 7 of 15
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tomatic and symptomatic individuals separately,
correlations are no longer evident. Namely, some HBV-
free symptomatics had elevated IgG anti-P. falciparum, but
without a parallel increase in factor-1 scores.
Medical records of previous episodes of clinical malaria
were available for both parasitaemic and exposed aparasi-
taemic subjects. Considering subjects of all groups
together, factor-1 scores of individuals with evidence for
P. falciparum infection in their last clinically diagnosed
episode were higher than for those who had had P. vivax
malaria (Mann-Whitney test: p < 0.01). Qualitatively, this
appeared to be the case for parasite carriers as for aparasi-
taemic subjects with reported previous malaria (Fig. 5),
although a valid statistical evaluation taking subject
groups into account is impossible due to the small sample
size. Nevertheless, it is interesting that the Plasmodium spe-
cies presently detected in the parasitaemic subjects, often
not identical with the one ascribed to the previous malaria
period, was not associated with a similar difference in
respect to factor-1 scores.
IgG reactivity to E. coli extract
Patterns of IgG reactivity were also assayed toward an
extract of E. coli whole cultures, which provided an inde-
pendent and completely different set of target antigens,
and, consequently, a different set of reactivity bands.
Polyclonal reactivity, parasitemia and anti-PF antibodiesFigure 4
Polyclonal reactivity, parasitemia and anti-PF antibodies. Relations of anti-brain IgG-derived PCA factor-1 scores are shown to 
parasitemia levels and anti-P. falciparum reactivity (ELISA absorbance, according to ref. 27). X and + indicate exposed apara-
sitemic subjects without and with previous malaria, respectively. The parameters were not always available from all subjects. 
Open symbols represent asymptomatic and closed symbols symptomatic subjects, all HBV-free.Page 8 of 15
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a result very similar to that described above for IgG
reactivity to human brain proteins (Fig. 6). Although less
significantly, the E. coli-derived score shared several prop-
erties described above. Analogously, asymptomatic para-
sitaemics had higher scores for reactivity to E. coli than
symptomatics in the absence (p = 0.041), but not in the
presence of HBV coinfection. Also similarly to IgG anti-
brain, this significance increased when only subjects
living less than 10 years in Apiacas were considered (p =
0.002, not shown). As can be seen in Fig. 7, factor-1 scores
calculated from anti-E. coli IgG reactivities indeed corre-
lated highly with anti-brain-IgG-derived factor-1 scores
(Spearman rank correlation: +0.70; p < 1E-9). Finally, IgG
anti-E. coli-derived factor-1 scores were higher in subjects
reporting previous infection with P. falciparum, compared
to P. vivax infection (p < 0.05; Fig. 8).
When principal components were calculated from IgG
reactivities to both brain and E. coli proteins together, the
properties described for both respective factor-1 scores fell
together in the resulting first principal component (Fig.
9), indicating again that they were highly coincident. The
difference between HBV-free asymptomatic and sympto-
matic parasitaemic subjects reached a higher significance
level (p = 0.00005) than for factor-1 scores derived from
either extract alone.
IgM reactivity to human brain proteins
IgM reactivities to brain proteins were measured using the
same extract as described for IgG (data not shown). Gen-
erally, a smaller number of bands was detected. The IgM-
derived factor-1 included only positive loads like the IgG-
derived one. The scores of both were correlated (Spear-
man rank correlation: +0.55; p < 1E-6), and, as for IgG,
IgM-derived factor-1 scores were higher in asymptomatic
than in symptomatic parasitaemic individuals free of
HBV. However, IgM-derived factor-1 did not significantly
discriminate between them, except when only individuals
living less than 10 years in Apiacas were considered (p =
0.013). No significant difference was found either in
respect to previously or presently detected Plasmodium
Polyclonal IgG to brain proteins and Plasmodium species in previous and present infectionsFigure 5
Polyclonal IgG to brain proteins and Plasmodium species in previous and present infections. Association of anti-brain IgG 
derived PCA factor-1 scores and Plasmodium species detected in the previous clinical Malaria episode (A), or presently (B). 
Medians calculated for all indicated subjects are shown by vertical bars. Subjects in which both species were detected at the 
same time were not considered. Crosses indicate exposed aparasitemic subjects with previous malaria, circles HBV-, and 
rhombi HBV+ parasite carriers. Open symbols represent asymptomatic and closed symbols symptomatic subjects.Page 9 of 15
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parasitaemics, a remarkable positive correlation existed
between IgM-derived factor-1 scores and individual age
(Spearman rank correlation: +0.41; p = 0.005), and also
with times spent in Apiacas (+0.34; p = 0.03), but not
within aparasitaemic subjects. As for IgG anti-brain, there
was no significant correlation with blood parasitaemia
levels, but with specific IgG anti-P. falciparum (+0.55; p <
1E-5).
Joint analysis of IgG and IgM reactive to brain proteins 
reveals distinct components
Finally, principal components were calculated for IgG and
IgM reactivities to human brain proteins together (Fig.
10). Surprisingly, the properties of the respective first
factors calculated for each isotype alone did not coincide
in a single principal component, as it had occurred in the
co-calculation of IgG anti-brain and anti-E. coli reactivi-
ties. Instead, the first two principal components (factor-1
and factor-2) of the co-calculation both significantly
distinguished between HBV-free asymptomatic and symp-
tomatic parasite carriers (Factor 1: p = 0.013; Factor 2: p =
0.004), and, as above, not between those infected with
HBV. Scores of both factors were enhanced in asympto-
matic subjects. Since principal components in the same
set are by definition uncorrelated, these two factors appear
to represent separate effects associated with clinical states.
Factor-1, characterized by positive loads as the above
described, was however positively influenced primarily by
IgM reactivity, and properties of factor-1 scores were sim-
ilar to those of the IgM-derived factor-1. Within parasitae-
mic subjects, scores increased with age (Spearman R:
+0.39; p = 0.007), with exposure times in Apiacas and in
endemic areas (+0.29 and +0.26, but not significant), and
were correlated with anti-P. falciparum IgG (+0.32; p <
IgG reactivity to E. coli proteinsFigure 6
IgG reactivity to E. coli proteins. Distributions of PCA factor-
1 scores derived from IgG reactivities to E. coli proteins per 
group. Group medians are indicated by vertical bars.
IgG reactivity to different antigenic sources is highly correl tedFigure 7
IgG reactivity to different antigenic sources is highly corre-
lated. IgG anti-brain and anti-E. coli derived PCA factor-1 
scores, respectively, are displayed in two dimensions. N indi-
cates non-exposed, X and + exposed aparasitemic subjects 
without and with previous malaria, respectively (B,C). Circles 
indicate HBV-, rhombi HBV+ parasitemics, open symbols 
asymptomatic and closed symbols symptomatic subjects.Page 10 of 15
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elevated in respect to P. falciparum but not P. vivax pre-
exposure (p = 0.01; not shown).
In contrast, factor-2 scores were positively influenced
mainly by IgG reactivity, while a number of IgM bands
had a negative impact. Thus, factor 2 can be said to
represent a certain IgG/IgM relationship. Remarkably,
among HBV-free parasite carriers, the highest scores were
characteristically found in asymptomatics who had only
been exposed to malaria in endemic areas for a limited
time. Factor-2 scores showed no significant association
with IgG anti-P. falciparum or with pre-exposure to Plasmo-
dium species. Instead, scores were slightly higher in sub-
jects presently infected with P. vivax, but not P. falciparum
(p = 0.04; not shown). Neither factor correlated signifi-
cantly with parasitaemia.
Association with reactivity to MSP1-19
Global IgG reactivity and subtype-specific reactivity have
been previously assayed including some subjects exam-
ined here [25]. Among parasitaemic subjects, IgG1, IgG2,
IgG3 and IgG4 anti-MSP1-19 all correlated significantly
with IgM-anti-brain-derived as well as with IgG/IgM-anti-
brain-derived factor-1, in particular IgG3 (Spearman R:
+0.68 [p < 0.001] and +0.62 [p < 0.01], respectively).
These values, however, did not corrrelate significantly
with any IgG-derived factor, nor with IgG/IgM-anti-brain-
derived factor-2. Only IgG anti-MSP1-19, measured in a
larger number of subjects, correlated positively with IgG-
anti-brain and IgG-anti-brain/E. coli-derived factor-1 (not
shown).
Discussion
Autoantibodies detected in the context of malaria infec-
tion are an old observation, reviewed in [27,28].
Polyclonal IgG to E. coli proteins and Plasmodium species in previous infectionFigure 8
Polyclonal IgG to E. coli proteins and Plasmodium species in 
previous infection. IgG anti-E. coli derived PCA factor-1 
scores are displayed against the parasite species detected in 
the previous malaria episode, in analogy to Fig. 5. Medians 
indicated by vertical bars include all subjects in the figure. 
Crosses represent exposed aparasitemic subjects with previ-
ous malaria, circles HBV-, and rhombi HBV+ parasite carri-
ers. Open symbols represent asymptomatic and closed 
symbols symptomatic subjects.
IgG reactivity to E. coli proteinsFigure 9
IgG reactivity to E. coli proteins. Distributions per group of 
PCA factor-1 scores derived from IgG reactivities to human 
brain and E. coli proteins joined together. Group medians are 
indicated by vertical bars.Page 11 of 15
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subjects and in acute symptomatic infection, while
asymptomatic infection has rarely been studied. However,
phospholipid-related specificities were found more ele-
vated in asymptomatics than in patients with malaria
symptoms [29,30]. All these previous studies focused on
antibody specificities otherwise known from autoim-
mune disease conditions, particularly systemic lupus ery-
thematosus. The findings were often interpreted as results
of specific crossreactivity or auto-immunization, and
analogies were regularly made to 'autoimmunity'. This
appears confusing, since malaria infection and pathologi-
cal autoimmunity have little obviously in common and,
in fact, the respective pathologies appear to mutually
inhibit rather than to facilitate each other [27].
The simultaneous standardized detection of multiple
immunoglobulin reactivities on immunoblots, as utilized
in the present study, is most likely to represent natural
antibody repertoires and, therefore, a way to approach the
problem of repertoire description in an unbiased way,
avoiding a potentially misleading disease- or otherwise
antigen- or specificity-oriented vision. Extracts of human
tissue (brain) or whole bacterial cultures were used as lig-
ands for antibodies with the aim of relating eventual
changes in binding patterns to clinical status, and compar-
ing whole reactivity patterns by multivariate analysis. The
same semiquantitative immunoblot technique has
previously demonstrated characteristics of natural IgM
and IgG reactivity patterns [17,31,32], among which sta-
bility [12,33,34] and independence of physiologic anti-
Principal components derived from IgG and IgM reactivities to human brain taken togetherFigure 10
Principal components derived from IgG and IgM reactivities to human brain taken together. A. Coefficients of factor 1 and 2, 
representing weight and direction of section reactivities contributing to the respective factor scores. B. Distributions of factor 
1 and 2 scores according to subject groups. Vertical bars represent medians within each group. C. Distribution of factor 1 and 
2 scores in respect to Malaria exposure (HBV-free parasite carriers only). Different subject groups are represented by the indi-
cated symbols.Page 12 of 15
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however, change with age [36], during human [13,14]
and experimental [37] autoimmune diseases and in
murine parasite infection [38].
The present results show that reactivity patterns to human
brain and E. coli proteins, unrelated to parasites, could dif-
ferentiate strikingly between asymptomatic and mild
symptomatic malaria infection. Asymptomatic subjects
generally showed elevated reactivity, which was concord-
ant but far more characteristic when compared with anti-
plasmodial IgG measures in the same sample. Thus, Plas-
modium infection is able to alter reactivity patterns to tar-
get proteins without relation to the parasite particularly in
asymptomatic subjects. Only co-infection with HBV,
known to be frequent in our study population [39],
heightened reactivity regardless of malaria symptoms and
obscured this discrimination when disregarded. This
effect is most probably unrelated to malaria, since chronic
HBV infection itself is known for its association with a
variety of autoantibodies [40]. Remarkably similar results
were obtained by analyses of IgG immunoblot reactivity
against extracts of human brain and of E. coli. In both
cases, the same major properties were represented by a
single respective principal component, characterized by
positive loads. Both were highly correlated and when reac-
tivity to both extracts was analysed together, they coin-
cided in a single PCA factor with maximal discriminatory
power, allowing to separate 13/15 (87%) of the HBV-free
asymptomatics from symptomatic patients. Thus, IgG
reactivity patterns to brain and to E. coli proteins behaved
somewhat like fragments of a hologram which, added
together, show the same image with increased resolution.
Other than previous data on malaria-associated autoanti-
bodies, these observations cannot easily be attributed to
specific immune responses, despite a positive correlation
with anti-parasite reactivity. Instead, they probably reflect
another phenomenon well known for malaria and other
parasite infections, that of polyclonal lymphocyte
activation. Polyclonal activation, however, is often dis-
cussed as an immune evasion mechanism, beneficial pri-
marily for parasites. Our results show in contrast that the
production of polyclonal IgG was associated with protec-
tion in asymptomatic parasite carriers, and that polyclo-
nal reactions appeared to have at least short-term
protective effects. A reason for this discrepancy may be
that earlier studies of polyclonal activation [41] assessed
peripheral plaque-forming cells, which may not contrib-
ute much to circulating antibody repertoires, and not the
recruitment of resident plasma cells with a relevant
lifespan from which circulating natural antibodies likely
originate. When such natural antibodies as they are
addressed by us have pre-existent protective properties,
their polyclonal recruitment can well be efficient and pro-
tective, as it has been demonstrated for other infections
[2,3,5]. This could be due to preceding evolutionary selec-
tion. Our observation of an effect of the parasite species
present in previous clinical episodes further suggests that
previous antigenic experience can trigger not only classical
recall responses, but also this capacity to react polyclon-
ally. With increasing exposure time, this nonspecific
recruitment of natural repertoires could be stepwise com-
plemented by induced parasite-specific antibodies, lead-
ing to an increasingly adapted protection as it is observed
in long-term exposed subjects.
Remarkably, in our study, asymptomatic and sympto-
matic infections were indeed best discriminated in sub-
jects with relatively short exposure times. In contrast to
previous data on autoantibodies, this indicates that the
reactivity shift in asymptomatic subjects described here
does not result from long-term adaptation to the parasite,
but is representative of an intermediate state of adapta-
tion. This interpretation is most clearly supported by the
result of joint analysis of IgM and IgG reactivity to brain
proteins, where two distinct principal components
appeared. Factor-1, representing a general elevation of all
reactivities with dominant IgM impact, shows an evident
overall time dependency in parasite carriers and may,
thus, reflect long-term adaptation. However, factor-2 dis-
criminated asymptomatic from symptomatic infections
best and, most characteristically, those asymptomatic sub-
jects who had been least exposed. Factor-2 represented a
relative dominance of IgG reactivity against some IgM.
Thus, in order to remain asymptomatic, particularly
infected subjects without long-term adaptation to the par-
asite may require a pattern of natural antibody production
dominated by IgG but not IgM.
This is in principal agreement with known protective
effects of antibodies. Classically, passive transfer of
hyperimmune IgG to patients infected with P. falciparum
has shown that antibodies play a crucial role in control-
ling blood stage parasitaemia [42,43]. The gradual acqui-
sition of clinical immunity to malaria after repeated
infection is positively correlated with the development of
a diverse IgG repertoire, most clearly including IgG reac-
tive to parasitized red blood cells [1]. Such cytophilic
antibodies are predominant in clinically immune individ-
uals living in hyperendemic areas [21]. In contrast to IgG,
IgM with the same cytophilic properties is associated with
rosetting and enhanced pathogenicity [44-47].
The targets of cytophilic antibodies include diverse and
highly variable parasite-encoded proteins, but also host
proteins such as 'band 3' [6], which is involved in parasite
entry into red blood cells [7]. Nevertheless, anti-band 3
antibodies may just exemplify the possible relevance of
natural repertoires, since they are originally known asPage 13 of 15
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clearance of senescent and damaged (including infected)
erythrocytes [8]. Intrinsic tuning of the production rate of
such pre-existing antibodies may, therefore, contribute as
much to the control of parasitaemia that occurs in clini-
cally immune individuals, as do cytophilic antibodies
originating from parasite-specific responses. Other natu-
ral antibody-mediated effects could act analogously, and
an appropriate individual reshaping of the natural
repertoire toward such components could well lead to a
capability to regulate parasitaemia, triggered by parasite-
mediated polyclonal lymphocyte activation. Such
reshaping, associated with a shift in internal self-recogni-
tion, could also explain the appearance of lupus-like
autoantibodies in chronically exposed subjects [28] with-
out, however, indicating autoimmunity. In general, pro-
tective natural repertoire components appear to deserve
further investigation, since vaccines and other malaria
control strategies could possibly be designed to make use
of them.
Conclusions
This study shows that simultaneous detection of IgM and
IgG reactivities to a broad range of targets can reveal
remarkable properties which are not easily accessible by
the usual specificity-focussed approaches. Thus, clinical
states in Plasmodium infection appear to depend on inter-
nal activation states which can be distinguished by differ-
ent patterns of polyclonal antibody production.
Particularly, asymptomatic but not symptomatic infection
of HBV-free subjects without extensive pre-exposure to
malaria was characterized by elevated polyclonal IgG reac-
tivity in absolute terms and in relation to IgM, further-
more appearing to be triggered by previous P. falciparum
but not P. vivax infections.
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